These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
433 related items for PubMed ID: 22189902
1. [Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy]. Erbe S, Gutwinski S, Bschor T. Psychiatr Prax; 2012 Mar; 39(2):57-63. PubMed ID: 22189902 [Abstract] [Full Text] [Related]
2. Second-generation antipsychotics for major depressive disorder and dysthymia. Komossa K, Depping AM, Gaudchau A, Kissling W, Leucht S. Cochrane Database Syst Rev; 2010 Dec 08; (12):CD008121. PubMed ID: 21154393 [Abstract] [Full Text] [Related]
5. Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder. Taneja C, Papakostas GI, Jing Y, Baker RA, Forbes RA, Oster G. Ann Pharmacother; 2012 May 08; 46(5):642-9. PubMed ID: 22550279 [Abstract] [Full Text] [Related]
8. Atypical antipsychotics: newer options for mania and maintenance therapy. Vieta E, Goikolea JM. Bipolar Disord; 2005 May 08; 7 Suppl 4():21-33. PubMed ID: 15948764 [Abstract] [Full Text] [Related]
9. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis. Cruz N, Sanchez-Moreno J, Torres F, Goikolea JM, Valentí M, Vieta E. Int J Neuropsychopharmacol; 2010 Feb 08; 13(1):5-14. PubMed ID: 19638254 [Abstract] [Full Text] [Related]
10. Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization. Jin H, Shih PA, Golshan S, Mudaliar S, Henry R, Glorioso DK, Arndt S, Kraemer HC, Jeste DV. J Clin Psychiatry; 2013 Jan 08; 74(1):10-8. PubMed ID: 23218100 [Abstract] [Full Text] [Related]
12. Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol. Goikolea JM, Colom F, Torres I, Capapey J, Valentí M, Undurraga J, Grande I, Sanchez-Moreno J, Vieta E. J Affect Disord; 2013 Jan 25; 144(3):191-8. PubMed ID: 23089129 [Abstract] [Full Text] [Related]
13. Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder. Wen XJ, Wang LM, Liu ZL, Huang A, Liu YY, Hu JY. Braz J Med Biol Res; 2014 Jul 25; 47(7):605-16. PubMed ID: 24919175 [Abstract] [Full Text] [Related]
14. Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study. Lin CY, Tsai GE, Wang HS, Wu YH, Chiou CC, Wu VY, Lane HY. J Clin Psychiatry; 2014 Sep 25; 75(9):e924-31. PubMed ID: 25295435 [Abstract] [Full Text] [Related]
15. Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. McDougle CJ, Stigler KA, Erickson CA, Posey DJ. J Clin Psychiatry; 2008 Sep 25; 69 Suppl 4():15-20. PubMed ID: 18533764 [Abstract] [Full Text] [Related]
18. Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews. Melnik T, Soares BG, Puga ME, Atallah AN. Sao Paulo Med J; 2010 May 25; 128(3):141-66. PubMed ID: 20963366 [Abstract] [Full Text] [Related]